Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/843,428external-prioritypatent/US9301920B2/en
Application filed by Therapeuticsmd IncfiledCriticalTherapeuticsmd Inc
Publication of AR095619A1publicationCriticalpatent/AR095619A1/en
Reivindicación 1: Una formulación farmacéutica para administrar estradiol, progesterona, o estradiol y progesterona a un mamífero que lo necesite, que comprende (i) estradiol solubilizado, (ii) progesterona totalmente solubilizada, (iii) progesterona parcialmente solubilizada/parcialmente micronizada, (iv) estradiol solubilizado y progesterona totalmente solubilizada, o (v) estradiol solubilizado y progesterona parcialmente solubilizada/parcialmente micronizada, en un aceite en donde el aceite comprende un éster de ácido graso de cadena media o mezclas de los mismos.Claim 1: A pharmaceutical formulation for administering estradiol, progesterone, or estradiol and progesterone to a mammal in need thereof, comprising (i) solubilized estradiol, (ii) fully solubilized progesterone, (iii) partially solubilized / partially micronized progesterone, (iv ) solubilized estradiol and fully solubilized progesterone, or (v) solubilized estradiol and partially solubilized / partially micronized progesterone, in an oil wherein the oil comprises a medium chain fatty acid ester or mixtures thereof.
ARP140101244A2013-03-152014-03-17
FORMULATION AND THERAPIES FOR HORMONAL REPLACEMENT OF NATURAL COMBINATION
AR095619A1
(en)
NEW INDAZOLCARBOXAMIDS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
New substituted indazoles, procedures for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines.
Pharmaceutical composition comprising micronized progesterone and type II safflower oil; and use for the treatment of a condition related to insufficient progesterone secretion.
OPHTHALMIC COMPOSITION INCLUDING AN ANDROGEN AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN EYE DISEASE RESULTING FROM AN ANDROGENIC DEFICIENCY
DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAENO 3-SUBSTITUTED, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES